Trial · NCT01453205
Adverse events570
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 570
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Rituximab+ ICE/DHAP | 47 | 79 | 113 |
| other | Anaemia | Blood and lymphatic system disorders | MEDI-551 2 mg/kg + ICE/DHAP | 32 | 52 | 87 |
| other | Anaemia | Blood and lymphatic system disorders | MEDI-551 4 mg/kg + ICE/DHAP | 33 | 54 | 111 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Rituximab+ ICE/DHAP | 6 | 79 | 6 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | MEDI-551 2 mg/kg + ICE/DHAP | 2 | 52 | 2 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | MEDI-551 4 mg/kg + ICE/DHAP | 3 | 54 | 4 |
| other | Granulocytopenia | Blood and lymphatic system disorders | Rituximab+ ICE/DHAP | 3 | 79 | 5 |
| other | Granulocytopenia | Blood and lymphatic system disorders | MEDI-551 2 mg/kg + ICE/DHAP | 0 | 52 | 0 |
| other | Granulocytopenia | Blood and lymphatic system disorders | MEDI-551 4 mg/kg + ICE/DHAP | 2 | 54 | 4 |
| other | Leukopenia | Blood and lymphatic system disorders | Rituximab+ ICE/DHAP | 8 | 79 | 10 |
| other | Leukopenia | Blood and lymphatic system disorders | MEDI-551 2 mg/kg + ICE/DHAP | 6 | 52 | 8 |
| other | Leukopenia | Blood and lymphatic system disorders | MEDI-551 4 mg/kg + ICE/DHAP | 10 | 54 | 31 |
| other | Lymphopenia | Blood and lymphatic system disorders | Rituximab+ ICE/DHAP | 4 | 79 | 22 |
| other | Lymphopenia | Blood and lymphatic system disorders | MEDI-551 2 mg/kg + ICE/DHAP | 2 | 52 | 18 |
| other | Lymphopenia | Blood and lymphatic system disorders | MEDI-551 4 mg/kg + ICE/DHAP | 3 | 54 | 4 |
| other | Neutropenia | Blood and lymphatic system disorders | Rituximab+ ICE/DHAP | 27 | 79 | 50 |
| other | Neutropenia | Blood and lymphatic system disorders | MEDI-551 2 mg/kg + ICE/DHAP | 15 | 52 | 30 |
| other | Neutropenia | Blood and lymphatic system disorders | MEDI-551 4 mg/kg + ICE/DHAP | 18 | 54 | 45 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Rituximab+ ICE/DHAP | 47 | 79 | 172 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | MEDI-551 2 mg/kg + ICE/DHAP | 24 | 52 | 71 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01453205/events